Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Chicago
Stanford University
Mayo Clinic
Hangzhou GluBio Pharmaceutical Co., Ltd.
City of Hope Medical Center
American Regent, Inc.
University of Virginia
University of Alabama at Birmingham
AbbVie
Epigenetix, Inc.
Astex Pharmaceuticals, Inc.
Fox Chase Cancer Center
Newave Pharmaceutical Inc
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center
Lynk Pharmaceuticals Co., Ltd
Prelude Therapeutics
Taiga Biotechnologies, Inc.
Medigene AG
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Daiichi Sankyo
Mayo Clinic
University of Pittsburgh
Stanford University
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
California Cancer Consortium
Massachusetts General Hospital
University of Louisville
Yale University
Prescient Therapeutics, Ltd.
Alliance for Clinical Trials in Oncology
JW Pharmaceutical
City of Hope Medical Center
National Cancer Institute (NCI)
Children's Oncology Group
Indiana University
Indiana University
National Cancer Institute (NCI)
Millennium Pharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)